XML 48 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814

Revenues (Tables)

9 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three and nine months ended September 30, 2015 and 2014:

	Three months ended September 30,								Nine months ended September 30,
	2015				2014				2015				2014
Products:
Acetadote	$	2,065,081			$	3,242,014			$	6,386,767			$	9,026,919
Omeclamox-Pak	691,120				996,974				2,393,495				3,481,264
Kristalose	3,939,294				3,967,885				12,160,037				10,903,255
Vaprisol	670,621				653,070				2,199,645				2,022,835
Caldolor	352,343				821,024				2,007,076				1,950,106
Other	166,589				48,080				334,543				188,080
Total net revenues	$	7,885,048			$	9,729,047			$	25,481,563			$	27,572,459

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 280



-SubTopic 10



-Section 50



-Paragraph 40



-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration